Published in Br J Cancer on June 01, 1991
Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ Health Perspect (2000) 2.34
Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. Br J Cancer (1994) 1.88
Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet (2006) 1.83
Epidemiology of childhood brain tumours in Yorkshire, UK, 1974-95: geographical distribution and changing patterns of occurrence. Br J Cancer (1998) 1.70
Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet (1997) 1.69
Full breastfeeding and paediatric cancer. J Paediatr Child Health (2007) 1.65
Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes. Best Pract Res Clin Endocrinol Metab (2010) 1.35
Incidence and survival for cancer in children and young adults in the North of England, 1968-1995: a report from the Northern Region Young Persons' Malignant Disease Registry. Br J Cancer (2000) 1.29
Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology. J Mol Diagn (2009) 1.29
Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev (2009) 1.19
Constitutional aneuploidy and cancer predisposition. Hum Mol Genet (2009) 1.05
Gliomas in adults. Dtsch Arztebl Int (2010) 1.02
Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes. Fam Cancer (2008) 1.00
Immunogenetics and the aetiology of childhood leukaemia. Arch Dis Child (1994) 0.95
Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing. Eur J Pediatr (2015) 0.95
Childhood solid tumours in relation to infections in the community in Cumbria during pregnancy and around the time of birth. Br J Cancer (2002) 0.94
Cancer in children with nonchromosomal birth defects. J Pediatr (2012) 0.92
Cancers in the first-degree relatives of children with brain tumours. Br J Cancer (2000) 0.86
Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions. Br J Cancer (2016) 0.86
Perinatal and familial risk factors for brain tumors in childhood through young adulthood. Cancer Res (2014) 0.85
Epidemiology of primary brain tumors in childhood and adolescence in Kuwait. Springerplus (2013) 0.85
Role of bevacizumab therapy in the management of glioblastoma. Cancer Manag Res (2010) 0.84
Rare and unusual endocrine cancer syndromes with mutated genes. Semin Oncol (2010) 0.84
Birth anomalies and obstetric history as risks for childhood tumors of the central nervous system. Pediatrics (2011) 0.83
Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors. Cancer Genet (2014) 0.82
Incidence and survival of pediatric soft tissue sarcomas in moscow region, Russian Federation, 2000-2009. Sarcoma (2012) 0.81
Genetic predispositions and childhood cancer. Environ Health Perspect (1998) 0.81
Increased incidence of childhood, prostate and breast cancers in relatives of childhood cancer patients. Fam Cancer (2012) 0.81
Childhood solid tumours in relation to population mixing around the time of birth. Br J Cancer (2003) 0.80
Tongue carcinoma in an adult Down's syndrome patient: a case report. World J Surg Oncol (2009) 0.79
Association of early life factors and brain tumour risk in a cohort study. Br J Cancer (2008) 0.79
Clonality analysis suggests that early-onset acute lymphoblastic leukaemia is of single-cell origin and implies no major role for germ cell mutations in parents. Br J Cancer (1999) 0.78
Childhood cancer in children with congenital anomalies in Oklahoma, 1997 to 2009. Birth Defects Res A Clin Mol Teratol (2016) 0.78
Somatic mutations in cancer development. Environ Health (2011) 0.77
Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma. Pediatr Blood Cancer (2009) 0.75
SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature. Childs Nerv Syst (2016) 0.75
The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (1981) 25.60
A classification scheme for childhood cancer. Int J Cancer (1987) 4.24
Second primary neoplasms in patients with retinoblastoma. Br J Cancer (1986) 3.57
Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med (1989) 3.03
Mutation and cancer: neuroblastoma and pheochromocytoma. Am J Hum Genet (1972) 2.99
Optic glioma of childhood. Natural history and rationale for conservative management. Br J Ophthalmol (1969) 2.33
Heredity and cancer in man. Prog Med Genet (1973) 1.91
Familial neuroblastoma. Report of a kindred with multiple disorders, including neuroblastomas in four siblings. N Engl J Med (1967) 1.90
Tuberous sclerosis: a new estimate of prevalence within the Oxford region. J Med Genet (1984) 1.81
Malignancy in neurofibromatosis. Adv Neurol (1981) 1.81
Age distribution of Wilms' tumor: report from the National Wilms' Tumor Study. Cancer Res (1988) 1.76
Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci U S A (1983) 1.72
Excess risk of breast cancer in the mothers of children with soft tissue sarcomas. Br J Cancer (1984) 1.70
Progeny of childhood-cancer survivors. Lancet (1974) 1.56
Occurrence of childhood cancers among sibs and estimation of familial risks. J Med Genet (1977) 1.37
Testicular cancers in children: epidemiologic characteristics. J Natl Cancer Inst (1972) 1.28
Rhabdomyosarcoma complicating multiple neurofibromatosis. J Pediatr (1978) 1.26
Inheritance and testicular cancer. Arguments based on a report of 3 cases and a review of the literature. Oncology (1987) 1.25
Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer (1989) 1.21
Cancer among 1,348 offspring of survivors of childhood cancer. Int J Cancer (1989) 1.21
Neurofibromatosis in children with soft tissue sarcoma. Pediatr Hematol Oncol (1988) 1.21
Neurofibromatosis and childhood tumors. Cancer (1986) 1.17
Hodgkin's disease in siblings. N Engl J Med (1977) 1.15
Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls. N Engl J Med (1975) 1.14
Pre-natal factors in the origin of germ cell tumours of childhood. Carcinogenesis (1982) 1.13
Breast cancer risk in mothers of children with osteosarcoma and chondrosarcoma. Br J Cancer (1986) 1.12
Frequency of 13q abnormalities among 203 patients with retinoblastoma. J Natl Cancer Inst (1989) 1.09
Genetic abnormalities in men with germ cell tumors. J Urol (1988) 1.07
[Genetic study of retinoblastoma (author's transl)]. Humangenetik (1974) 1.03
Primary carcinoma of the liver in childhood: an epidemiologic study. J Natl Cancer Inst (1968) 1.02
Teratomas in children: epidemiologic features. J Natl Cancer Inst (1973) 1.01
Association between hepatoblastoma and polyposis coli. Arch Dis Child (1983) 0.98
Acute childhood leukemia: epidemiologic study by cell type of 1,263 cases at the Children's Cancer Research Foundation in Boston, 1947-65. J Natl Cancer Inst (1971) 0.98
Medical and drug risk factors associated with neuroblastoma: a case-control study. J Natl Cancer Inst (1987) 0.98
Epidemiological investigations on neuroblastomas in Denmark 1943-1980. Br J Cancer (1986) 0.91
Hepatoblastoma in infant sisters. Cancer (1969) 0.90
Causes of death to age 30 in Down syndrome. Am J Hum Genet (1988) 0.89
Life tables for Down syndrome. Hum Genet (1989) 0.89
Down's syndrome and leukaemia. Lancet (1972) 0.88
Hepatoblastoma in families with polyposis coli. JAMA (1987) 0.86
Childhood malignant melanoma. Incidence and etiology. Am J Pediatr Hematol Oncol (1985) 0.85
Heritable fraction of unilateral Wilms tumor. Pediatrics (1988) 0.84
Adrenal cortical tumours: epidemiological and familial aspects. Arch Dis Child (1987) 0.83
[A French genetic and epidemiologic study on nephroblastoma: preliminary results]. Bull Cancer (1988) 0.82
Survivors of neuroblastoma and ganglioneuroma and their families. J Med Genet (1982) 0.82
Leukaemia in children with Down's syndrome. Oncology (1983) 0.81
Testicular cancer in children. Cancer (1980) 0.79
Epidemiology of selected sarcomas in children. J Natl Cancer Inst (1974) 0.78
Adrenocortical carcinoma in two children with subsequent primary tumors. Am J Dis Child (1978) 0.78
Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet (1991) 6.61
Successful small-bowel/liver transplantation. Lancet (1990) 4.85
The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med (1994) 4.65
Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc Natl Acad Sci U S A (1987) 3.98
Activation and somatic mutation of the translocated c-myc gene in burkitt lymphoma cells. Cell (1984) 3.66
Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C lambda locus in Burkitt. Proc Natl Acad Sci U S A (1983) 3.53
Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene. J Virol (1991) 3.03
Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma. Nature (1982) 3.03
Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. J Virol (1990) 2.58
Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (1996) 2.33
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J Natl Cancer Inst (1998) 2.33
Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet (1997) 2.15
Geographical prevalence of two types of Epstein-Barr virus. Virology (1986) 2.05
A polymorphic stop codon in BRCA2. Nat Genet (1996) 1.95
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat Genet (1996) 1.79
A BRCA1 nonsense mutation causes exon skipping. Am J Hum Genet (1998) 1.77
Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives. EMBO J (1985) 1.76
A variant translocation places the lambda immunoglobulin genes 3' to the c-myc oncogene in Burkitt's lymphoma. Nature (1984) 1.75
A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) Burkitt lymphoma. Cell (1984) 1.74
The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. IARC Sci Publ (1985) 1.73
A breast-ovarian cancer susceptibility gene maps to chromosome 17q21. Am J Hum Genet (1993) 1.66
Chromosome study of Ewing's sarcoma (ES) cell lines. Consistency of a reciprocal translocation t(11;22)(q24;q12). Cancer Genet Cytogenet (1984) 1.65
Identification of the coding region for a second Epstein-Barr virus nuclear antigen (EBNA 2) by transfection of cloned DNA fragments. EMBO J (1985) 1.65
Improved techniques for kidney transplantation in mice. Microsurgery (1995) 1.63
Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma. Int J Cancer (1985) 1.62
Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma. Int J Cancer (1986) 1.62
Childhood cancer survival in Europe. Ann Oncol (2003) 1.57
Identification of Epstein-Barr virus terminal protein 1 (TP1) in extracts of four lymphoid cell lines, expression in insect cells, and detection of antibodies in human sera. J Virol (1990) 1.56
An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? Am J Hum Genet (1999) 1.52
Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A. In Vitro Cell Dev Biol (1986) 1.51
A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res (1997) 1.49
PTEN germ-line mutations in juvenile polyposis coli. Nat Genet (1998) 1.45
A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet (1996) 1.45
Breakpoints of Burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC. Genes Chromosomes Cancer (1994) 1.40
Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responses in vitro. Int J Cancer (1984) 1.37
Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res (1999) 1.36
Successful intestinal transplantation in pigs treated with cyclosporine. Transplantation (1988) 1.36
Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene. J Med Genet (2009) 1.35
Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet (2000) 1.34
Incidence, survival and prevalence of myeloid malignancies in Europe. Eur J Cancer (2012) 1.32
Molecular characterization of the Epstein-Barr virus DNA in three new Burkitt's lymphoma-derived cell lines. Mol Biol Med (1984) 1.27
Population mixing and excess of childhood leukemia. BMJ (1993) 1.24
Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Oncogene (1998) 1.21
Neuroectoderm-associated antigens on Ewing's sarcoma cell lines. Cancer Res (1987) 1.21
An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes Cancer (2000) 1.21
Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine. J Clin Endocrinol Metab (1998) 1.18
Ultrasound examinations in pregnancy and childhood cancer. Lancet (1984) 1.17
Cancer survival in European adolescents and young adults. Eur J Cancer (2003) 1.17
Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine. Am J Hum Genet (1997) 1.16
Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues. Int J Cancer (2000) 1.15
Linked markers flanking the gene for multiple endocrine neoplasia type 2A. Genomics (1989) 1.13
Sensation and Distress of Pain Scales: reliability, validity, and sensitivity. J Nurs Meas (2001) 1.11
Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin. J Natl Cancer Inst (1984) 1.10
Molecular cloning and mapping of a human cDNA (PA2G4) that encodes a protein highly homologous to the mouse cell cycle protein p38-2G4. Cytogenet Cell Genet (1997) 1.07
Neurofibromatosis type 2 appears to be a genetically homogeneous disease. Am J Hum Genet (1992) 1.07
Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma. IARC Sci Publ (1985) 1.06
Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood (1992) 1.05
Structural analysis of both products of a reciprocal translocation between c-myc and immunoglobulin loci in Burkitt lymphoma. Nucleic Acids Res (1985) 1.05
Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb. Hum Mol Genet (1992) 1.05
Epstein-Barr virus markers in a series of Burkitt's lymphomas from the West Nile District, Uganda. Eur J Cancer Clin Oncol (1983) 1.04
Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation (1996) 1.03
IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions. J Immunol (1989) 1.03
Expression of P0- and P3-RNA from the normal and translocated c-myc allele in Burkitt's lymphoma cells. Oncogene (1990) 1.02
Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2. J Virol (1989) 1.02
Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer. Nat Genet (1994) 1.02
Presymptomatic diagnosis for neurofibromatosis 2 with chromosome 22 markers. Neurology (1993) 1.01
Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children. Br J Cancer (1982) 1.01
c-Ha-ras1 is not deleted in aniridia-Wilms' tumour association. Nature (1983) 1.01
Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A. Genomics (1990) 1.01
Refined technique for intestinal transplantation in the rat. Microsurgery (1991) 1.00
Combined small bowel and liver transplantation in the rat: possible role of the liver in preventing intestinal allograft rejection. Transplantation (1991) 1.00
Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context. Int J Cancer (1993) 1.00
Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation. Proc Natl Acad Sci U S A (1997) 1.00
Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells. FASEB J (2000) 0.98
A large multisite cancer family is linked to BRCA2. J Med Genet (1995) 0.98
Variant translocation in a non endemic case of Burkitt's lymphoma: t (8;22) in an Epstein--Barr virus negative tumour and in a derived cell line. Eur J Cancer (1981) 0.98
Epstein-Barr virus-specific DNA polymerase in virus-nonproducer Raji cells. J Virol (1986) 0.98
Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG-->ATG) mutation. Surgery (2000) 0.97
Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations. Oncogene (1997) 0.97
Up-to-date monitoring of childhood cancer long-term survival in Europe: tumours of the sympathetic nervous system, retinoblastoma, renal and bone tumours, and soft tissue sarcomas. Ann Oncol (2007) 0.97
Comparison of chemical composition of peritoneal fluid and serum: a method for monitoring dialysis patients and a tool for assessing binding to serum proteins in vivo. Ann Intern Med (1978) 0.97
Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function? Hum Mutat (1999) 0.96
Measurement of antibodies to varicella-zoster virus in a tropical population by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 0.96
Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families. Cancer Res (1996) 0.95
BRCA2 hereditary breast cancer pathophenotype. Breast Cancer Res Treat (1997) 0.95
Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV). Int J Cancer (1990) 0.95
Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines. Oncogene (1998) 0.95
Abnormal expression of vimentin intermediate filaments in human lymphoid cell lines with deletion or translocation of the distal end of chromosome 8. J Natl Cancer Inst (1984) 0.94
Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma. J Med Genet (2005) 0.92
No evidence for differences in the Epstein-Barr virus genome carried in Burkitt lymphoma cells and nonmalignant lymphoblastoid cells from the same patients. Proc Natl Acad Sci U S A (1984) 0.92
Intestinal permeability and bacterial translocation following small bowel transplantation in the rat. Transplantation (1991) 0.91
Antibody response against the Epstein-Barr virus-coded nuclear antigen2 (EBNA2) in different groups of individuals. Int J Cancer (1987) 0.91
Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats. Brain Res (2000) 0.91
BRCA2 mutations in hereditary breast and ovarian cancer in France. Am J Hum Genet (1997) 0.91
Where to next with extracranial rhabdoid tumours in children. Eur J Cancer (2004) 0.90
Intestinal transplantation in the mouse. Transplantation (1993) 0.90
Germline brca2 sequence variants in patients with ocular melanoma. Int J Cancer (1999) 0.90
Geographical comparison of cancer survival in European children (1988-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer (2006) 0.89